Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech symbols : ALNY save search
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: -6.87%
H: 0.0%
C: 0.0%
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -1.04%
H: 0.0%
C: 0.0%
ALNY | News | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -2.95%
H: 0.0%
C: 0.0%
financial results technology report results biotech iot
Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 to Achieve a Functional Cure for Chronic Hepatitis B Virus (HBV) Infection at AASLD The Liver Meeting®
Published: 2021-11-12 (Crawled : 13:15) - globenewswire.com
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 4.66%
H: 0.0%
C: 0.0%
ALNY | News | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -2.06%
H: 0.0%
C: 0.0%
hepatitis potential biotech technology iot liver injection infections chronic hepatitis b
Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B Data Accepted for Presentation at AASLD’s The Liver Meeting® 2021
Published: 2021-10-15 (Crawled : 14:00) - biospace.com/
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: -0.02%
H: 3.08%
C: -2.81%
ALNY | News | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.34%
H: 0.09%
C: -0.69%
presentation hepatitis biotech technology iot liver
Vir Biotechnology Initiates Phase 2 Clinical Trial Evaluating the Combination of VIR-2218 and VIR-3434 as a Functional Cure Regimen for Chronic Hepatitis B Virus Infection
Published: 2021-07-15 (Crawled : 14:00) - biospace.com/
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 0.08%
H: 2.71%
C: 2.31%
ALNY | News | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.16%
H: 1.35%
C: 1.11%
phase 2 hepatitis biotech technology iot trial injection infections chronic hepatitis b
Vir Biotechnology Presents New Clinical Data from Ongoing Trials of VIR-2218 and VIR-3434 in Patients with Chronic Hepatitis B Virus Infection at the International Liver Congress 2021
Published: 2021-06-25 (Crawled : 13:00) - globenewswire.com
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: -0.52%
H: 1.36%
C: -7.74%
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.06%
H: 1.28%
C: 1.1%
ALNY | News | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.26%
H: 1.5%
C: 0.72%
hepatitis ongoing biotech technology iot liver trial injection infections chronic hepatitis b
Immuneering Expands Board of Directors with Addition of Senior Biotechnology Executive Laurie Keating
Published: 2021-04-27 (Crawled : 19:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.65%
H: 0.06%
C: -0.24%
ALNY | News | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.53%
H: 1.35%
C: -0.59%
biotech technology iot
Brii Biosciences, Vir Biotechnology, and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B
Published: 2021-04-21 (Crawled : 12:00) - vbivaccines.com
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: -1.09%
H: 0.38%
C: 0.04%
VBIV | $0.6396 1.57% 1.55% 160K
|
Health Technology
|
| O: 0.0%
H: 7.66%
C: 7.66%
ALNY | News | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.67%
H: 1.12%
C: 0.43%
treatment phase 2 hepatitis vbi-2601 biotech vaccine technology iot brii-835 trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.